TPM3 |
PBX3 |
||
---|---|---|---|
Gene Name | tropomyosin 3 | pre-B-cell leukemia homeobox 3 | |
Image | No pdb structure | No pdb structure | |
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process |
|
||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS | |||
Protein-Protein Interactions | 41 interactors: ACTA1 ACTB BLOC1S6 C1orf216 CCDC102B CCDC114 CCDC146 CCHCR1 CNN1 FAM9C FBXO5 HDDC3 HSF2 IFIT3 IKBIP KCNE1 KIFC3 KXD1 LCA5L LURAP1 MAD1L1 MAGEA11 NEK2 OIP5 PBX3 S100A2 S100A4 SMAD3 SUMO4 SYCE1 TFPT THAP1 TLK1 TMOD1 TMOD2 TNNT1 TRAP1 TRIM27 TRIP6 VPS52 WASH3P | 14 interactors: AGTRAP ARL6IP1 FSD2 HOXA9 HOXB8 MAGEA1 MAGEC2 MAL2 MEIS1 RABAC1 TPM3 TRAF1 TRIM44 ZNHIT3 | |
Entrez ID | 7170 | 5090 | |
HPRD ID | 01840 | 15938 | |
Ensembl ID | ENSG00000143549 | ENSG00000167081 | |
Uniprot IDs | B4DQ80 P06753 Q5VU58 Q5VU63 Q8TCG3 | P40426 Q96AL5 | |
PDB IDs | |||
Enriched GO Terms of Interacting Partners? |
|
||
Tagcloud ? | aacr
accelerated
advancements
ago
approved
developments
discov
encodes
fda
fusions
harboring
next
ntrk1
oncd
oncogene
oncogenic
oncology
originally
precision
rationale
rearrangements
revisit
scientific
throughput
transforming
trk
trka
trkb
trkc
|
11q23
asxl1
bcor
blymphoid
btg1
cdkn2a
cgh
ebf1
entity
etv6
fulfilling
ikzf1
immunophenotypic
karyotyped
lef1
mbnl1
mef2c
monosomy
myeloblastic
notch1
p15
polysomy
q11
q21
q34
runx1
stil
tet2
trilineage
|
|
Tagcloud (Difference) ? | aacr
accelerated
advancements
ago
approved
developments
discov
encodes
fda
fusions
harboring
next
ntrk1
oncd
oncogene
oncogenic
oncology
originally
precision
rationale
rearrangements
revisit
scientific
throughput
transforming
trk
trka
trkb
trkc
|
11q23
asxl1
bcor
blymphoid
btg1
cdkn2a
cgh
ebf1
entity
etv6
fulfilling
ikzf1
immunophenotypic
karyotyped
lef1
mbnl1
mef2c
monosomy
myeloblastic
notch1
p15
polysomy
q11
q21
q34
runx1
stil
tet2
trilineage
|
|
Tagcloud (Intersection) ? |